TRENDS IN INCIDENCE AND MORTALITY FROM DISEASES INCLUDED IN DISEASE MANAGEMENT PROGRAMS: DIABETES MELLITUS, ARTERIAL HYPERTENSION, CHRONIC HEART FAILURE
Introduction. The number of non-communicable diseases (NCDs) is increasing worldwide, mainly cardiovascular diseases and diabetes mellitus. In Kazakhstan, disease management programs (DMP) for three nosologies have been introduced to reduce the risk of NCDs.
Aim: To study incidence and mortality rates trends from three nosologies included in DMP: diabetes mellitus (DM), chronic heart failure (CHF) and arterial hypertension in Almaty city.
Materials and methods. The data were obtained from the National Scientific Center for Health Development in Almaty. For the incidence analysis, data were obtained from 2016 to 2023, since the PHI was implemented during this period, while for mortality, data were obtained from 2013 to 2023. To predict the number of incidence and mortality for three types of nosologies, the linear regression method
Results. The incidence per 100,000 population for all three nosologies is growing in all age groups: DM from 2230.5 to 3621.3, for hypertension from 6596.9 to 11811.3 and for CHF from 321.8 to 1432.9. An increase in mortality from diabetes mellitus was observed from 2.85 to 22.34, and a further increase to 42.48 per 100.000 population is expected. Similarly, an increase in hypertension was observed from 2.17 to 12.67 from 2013 to 2023, and its growth to 20.58 is expected by 2028. A decrease in CHF was observed from 20.21 to 9.20 by 2023, and a further reduction to 1.24 by 2028 is expected.
Conclusion. Our analysis shows an increase in the incidence of all three nosologies, in particular, diabetes and CHF at a young age, while hypertension and CHF in the age group of 60-74 years. Positive dynamics is the improvement in the coverage of patients involved in the PHC, but there has been a decrease in the proportion of patients in all three nosologies in the last two years
Oryngul Jumagazieva1, https://orcid.org/0000-0003-1914-7179
Ainur B. Qumar1, https://orcid.org/0000-0003-0457-7205
Kamila Faizullina1, https://orcid.org/0000-0002-2031-9444
Nazgul Akhtayeva1, https://orcid.org/0000-0002-0835-9814
Anuar D. Akhmetzhan1, https://orcid.org/0009-0009-7451-9706
Merekesh Brimzhanova2, https://orcid.org/0009-0008-9269-8982
Venera Baurzhan3
1. Antini C., Caixeta R., Luciani S., Hennis A.J.M. Diabetes mortality: trends and multi-country analysis of the Americas from 2000 to 2019. Int J Epidemiol. 2024 Feb 1;53(1). doi: 10.1093/ije/dyad182.
2. Beissova A., Kamkhen V., Turbekova M., Malgazhdarov M., Koshkimbayeva S., Kozhabek L. Epidemiological Features of Diabetes in Kazakhstan in 2018-2021 (Population Study). Med J Islam Repub Iran. 2023 Apr 10. 37:35. doi: 10.47176/mjiri.37.35.
3. Chan B.T., Rauscher C., Issina A.M., Kozhageldiyeva L.H., Kuzembaeva D.D., Davis C.L., Kravchenko H., Hindmarsh M., McGowan J., Kulkaeva G. A programme to improve quality of care for patients with chronic diseases, Kazakhstan. Bull World Health Organ. 2020 Mar 1;98(3):161-169. doi: 10.2471/BLT.18.227447. Epub 2019 Jan 27.
4. Coughlin S.S., Vernon M., Hatzigeorgiou C., George V. Health Literacy, Social Determinants of Health, and Disease Prevention and Control. J Environ Health Sci. 2020;6(1):3061. Epub 2020 Dec 16.
5. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22. Erratum in: Lancet. 2023 Sep 30;402(10408):1132. doi: 10.1016/S0140-6736(23)02044-5.
6. Galiyeva D., Gusmanov A., Sakko Y., Issanov A., Atageldiyeva K., Kadyrzhanuly K., Nurpeissova A., Rakhimzhanova M., Durmanova A., Sarria-Santamera A., Gaipov A. Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014-2019. BMC Endocr Disord. 2022 Nov 11;22(1):275. doi: 10.1186/s12902-022-01200-6.
7. Diabetes. Key facts. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed 5 April 2023)
8. Khan M.A.B., Hashim M.J., King J.K., Govender R.D., Mustafa H., Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020 Mar;10(1):107-111. doi: 10.2991/jegh.k.191028.001.
9. Kayupova G., Turdaliyeva B., Tulebayev K., Van Duong T., Chang P.W., Zagulova D. Health Literacy among Visitors of District Polyclinics in Almaty, Kazakhstan. Iran J Public Health. 2017 Aug;46(8):1062-1070.
10. Lu W.L., Yuan J.H., Liu Z.Y., Su Z.H., Shen Y.C., Li S.J., Zhang H. Worldwide trends in mortality for hypertensive heart disease from 1990 to 2019 with projection to 2034: data from the Global Burden of Disease 2019 study. Eur J Prev Cardiol. 2024 Jan 5;31(1):23-37. doi: 10.1093/eurjpc/zwad262.
11. Mills K.T., Stefanescu A., He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020 Apr;16(4):223-237. doi: 10.1038/s41581-019-0244-2.
12. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24. Erratum in: Lancet. 2022 Feb 5;399(10324):520. doi: 10.1016/S0140-6736(22)00061-7.
13. Pham B.N., Jorry R., Abori N., Silas V.D., Okely A.D., Pomat W. Non-communicable diseases attributed mortality and associated sociodemographic factors in Papua New Guinea: Evidence from the Comprehensive Health and Epidemiological Surveillance System. PLOS Glob Public Health. 2022 Mar 25;2(3). doi: 10.1371/journal.pgph.0000118.
14. Saeedi P., Salpea P., Karuranga S., Petersohn I., Malanda B., Gregg E.W., Unwin N., Wild S.H., Williams R. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2020 Apr. 162:108086. doi: 10.1016/j.diabres.2020.108086.
15. Savarese G., Becher P.M., Lund L.H., Seferovic P., Rosano G.M.C., Coats A.J.S. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023 Jan 18;118(17):3272-3287. doi: 10.1093/cvr/cvac013. Erratum in: Cardiovasc Res. 2023 Jun 13;119(6):1453. doi: 10.1093/cvr/cvad026.
16. Shahim B., Kapelios C.J., Savarese G., Lund L.H. Global Public Health Burden of Heart Failure: An Updated Review. Card Fail Rev. 2023 Jul 27;9. doi: 10.15420/cfr.2023.05.
17. Shayakhmetov S.S., Toguzbayeva K.K., Ismailova A.A., Tabibi R., Derbishalieva Z.K., Dzhusupov K.O. Health Literacy of Rural Population of Kazakhstan. Iran J Public Health. 2020 Jul;49(7):1269-1277. doi: 10.18502/ijph.v49i7.3580.
18. Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Stein C., Basit A., Chan J.C.N., Mbanya J.C., Pavkov M.E., Ramachandaran A., Wild S.H., James S., Herman W.H., Zhang P., Bommer C., Kuo S., Boyko E.J., Magliano D.J. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan. 183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6. Erratum in: Diabetes Res Clin Pract. 2023 Oct. 204:110945. doi: 10.1016/j.diabres.2023.110945.
19. Yerdessov S., Kadyrzhanuly K., Sakko Y., Gusmanov A., Zhakhina G., Galiyeva D., Bekbossynova M., Salustri A., Gaipov A. Epidemiology of Arterial Hypertension in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014-2019. J Cardiovasc Dev Dis. 2022 Feb 5;9(2):52. doi: 10.3390/jcdd9020052.
Количество просмотров: 1211
Категория статей:
Оригинальное исследование
Библиографическая ссылка
Jumagazieva O., Qumar A.B., Faizullina K., Akhtayeva N., Akhmetzhan A.D., Brimzhanova M., Baurzhan V. Trends in incidence and mortality from diseases included in disease management programs: Diabetes mellitus, Arterial hypertension, Chronic heart failure // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (4), pp. 31-38. doi 10.34689/SH.2024.26.4.004Похожие публикации:
USING THE ROBSON CLASSIFICATION TO ESTIMATE THE CAESAREAN SECTION RATE AND LOOK FOR WAYS TO REDUCE IT
CURRENT PRACTICE IN CARING FOR PEOPLE WITH DEMENTIA
АНAЛИЗ РЕЗУЛЬТАТОВ YЛЬТРAЗВYКOВOЙ ДИAГНOCТИКИ C ДOППЛEРOГРAФИEЙ ПРИ ДOБРOКAЧECТВEННЫX И ЗЛOКAЧECТВEННЫX OПYXOЛЯX ЩИТOВИДНOЙ ЖЕЛEЗЫ
EFFECT OF SEASONAL CHANGES ON SCORPION POISON
THERAPEUTIC EFFECTS OF MELATONIN IN AN ETHANOL-INDUCED GASTRIC ULCER MODEL